What is Sleepnet?
Sleepnet focuses on developing and manufacturing advanced respiratory masks for CPAP, NIV, and pediatric applications. Their product line, which includes full face and nasal masks, along with personal protective equipment, is designed to maximize user comfort and therapeutic effectiveness. The company serves both the home care and hospital sectors, targeting individuals with sleep apnea and other respiratory conditions, as well as healthcare providers and distributors. Sleepnet distinguishes itself through proprietary technologies such as AIRgel and Custom Fit Technology, ensuring a secure and comfortable fit for a diverse user base.
How much funding has Sleepnet raised?
Sleepnet has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Sleepnet
PPP
Public-Private Partnership
What's next for Sleepnet?
With a significant late-stage funding context, Sleepnet is poised for substantial growth and market expansion. The recent strategic investment likely signals confidence from backers in the company's proven track record and its capacity to scale operations. Future initiatives may involve further product innovation, broadening distribution channels, and potentially exploring new therapeutic areas within respiratory care. This capital infusion will be critical in solidifying Sleepnet's competitive advantage and meeting the increasing demand for advanced respiratory support solutions.
See full Sleepnet company page
